Categories Retail, U.S. Markets News

Arconic says it’s no longer available for sale; stock nosedives

Arconic Inc (ARNC) announced that the Board has determined to no longer pursue a potential sale of the company as part of its strategy and portfolio review. However, the company said that it will continue with the previously announced sale process of its Building and Construction Systems unit. Shares of Arconic tanked more than 25% in the pre-market trading on Tuesday.

For the past few months, it was reported that the public equity firm Apollo Global Management (APO) is eyeing to buy Arconic. Last Thursday, New York Post reported that Apollo is close to taking over Arconic in a deal valued at $10.6 billion.

Arconic’s Chairman John Plant stated that the company has been conducting a strategic review over the past year and as part of that process considered a sale of the company. He added that the New York-based company has not received a proposal for a full-company transaction that it believes would be in the best interests of Arconic’s shareholders and other stakeholders.

Related: Arconic Inc Q3 2018 earnings conference call transcript

In January 2018, Arconic initiated a review of its strategy and portfolio. As part of that review, the company initiated the sale process of Building and Construction Systems (BCS) business in July 2018.

In October 2018, Arconic sold its Texarkana, Texas rolling mill to Ta Chen International for about $300 million, plus additional contingent consideration of up to $50 million.

Alcoa Q4 earnings beat estimates amidst tough macro factors

Arconic stock, which plunged to a new 52-week low ($15.63) on December 26, 2018, opened at $16.70 on Tuesday morning. The stock had dropped 19% in the last three months and 45% in the past 52-weeks period.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top